Skip to main content
Log in

Detection and quantification of benzodiazepines and Z-drugs in human whole blood, plasma, and serum samples as part of a comprehensive multi-analyte LC-MS/MS approach

  • Research Paper
  • Published:
Analytical and Bioanalytical Chemistry Aims and scope Submit manuscript

Abstract

For the first time, a liquid chromatography-tandem mass spectrometry (LC-MS/MS) multi-analyte approach based on a simple liquid–liquid extraction was developed and validated for fast target screening and quantification of benzodiazepines and Z-drugs in case of driving ability and crime responsibility in the three most important biosamples whole blood, plasma, and serum. Whole blood, plasma, and serum (500 μL each) were extracted twice at pH 7.4 and at pH 10 with ether/ethyl acetate (1:1). Separation, detection, and quantification were performed using LC-MS/MS with electrospray ionization in positive mode. The method was validated with respect to selectivity, ion suppression/enhancement of co-eluting analytes, matrix effects, recovery, process efficiency, accuracy and precision, stabilities, and limits of detection and quantification. For accuracy and precision, full calibration was performed with ranges from subtherapeutic to toxic concentrations. The presented LC-MS/MS approach as part of a universal multi-analyte concept for over 100 drugs was applicable for selective detection as well as accurate and precise quantification in whole blood, plasma, and serum. The approach was selective, sensitive, accurate, and precise for 16 of the 19 tested drugs in whole blood, 18 in plasma, and 17 in serum. Only semiquantitative results could be obtained for zopiclone because of its instability in all tested biosamples.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Schweizerisches Zentrum für Qualitätskontrolle (2010) Serum oder plasma. www.cscq.ch/SiteCSCQ/FichierPDF_DE/serum_oder_plasma.pdf

  2. Remane D, Meyer MR, Wissenbach DK, Maurer HH (2011) Anal Bioanal Chem 400:2093–2107

    Article  CAS  Google Scholar 

  3. Remane D, Meyer MR, Wissenbach DK, Maurer HH (2011) Anal Bioanal Chem 401:1352

    Article  Google Scholar 

  4. Maurer HH (2005) Clin Biochem 38:310–318

    Article  CAS  Google Scholar 

  5. Kratzsch C, Tenberken O, Peters FT, Weber AA, Kraemer T, Maurer HH (2004) J Mass Spectrom 39:856–872

    Article  CAS  Google Scholar 

  6. Saar E, Gerostamoulos D, Drummer OH, Beyer J (2010) J Mass Spectrom 45:915–925

    Article  CAS  Google Scholar 

  7. Laloup M, Ramirez Fernandez MM, de Boeck G, Wood M, Maes V, Samyn N (2005) J Anal Toxicol 29:616–626

    Article  CAS  Google Scholar 

  8. Ambach L, Hernández Redondo A, König S, and Weinmann W. (2013) Drug Test Anal. Jul 19. doi:10.1002/dta.1505.

  9. Gonzalez O, Alonso RM, Ferreirós N, Weinmann W, Zimmermann R, Dresen S (2011) J Chromatogr B Anal Technol Biomed Life Sci 879:243–252

    Article  CAS  Google Scholar 

  10. van Laar MW, Volkerts ER (1998) CNS Drugs 10:383–396

    Article  Google Scholar 

  11. Steentoft A, Linnet K (2009) Forensic Sci Int 184:74–79

    Article  CAS  Google Scholar 

  12. Steentoft A, Worm K (1993) Forensic Sci Int 33:45–48

    CAS  Google Scholar 

  13. Kratzsch C, Tenberken O, Peters FT, Weber AA, Kraemer T, Maurer HH (2004) J Mass Spectrom 39:856–872

    Article  CAS  Google Scholar 

  14. Nakamura M (2011) Biomed Chromatogr 25:1283–1307

    Article  CAS  Google Scholar 

  15. Laloup M, Ramirez Fernandez MM, de Boeck G, Wood M, Maes V, Samyn N (2005) J Anal Toxicol 29:616–626

    Article  CAS  Google Scholar 

  16. Rust KY, Wilkens H, Kaiser R, Bregel D, Wilske J, Kraemer T (2012) Ther Drug Monit 34:729–735

    Article  CAS  Google Scholar 

  17. Maurer HH, Pfleger K, Weber AA (2011) Mass spectral and GC data of drugs, poisons, pesticides, pollutants and their metabolites. Wiley-VCH, Weinheim

    Google Scholar 

  18. Maurer HH, Kratzsch C, Kraemer T, Peters FT, Weber AA (2002) J Chromatogr B Anal Technol Biomed Life Sci 773:63–73

    Article  CAS  Google Scholar 

  19. Matuszewski BK, Constanzer ML, Chavez-Eng CM (2012) Anal Chem 75:3019–3030

    Article  Google Scholar 

  20. Peters FT, Paul LD, Musshoff F, Aebi B, Auwaerter V, Kraemer T, Skopp G (2009) Toxichem Krimtech 76:185–208

    Google Scholar 

  21. Shah VP, Midha KK, Findlay JW, Hill HM, Hulse JD, McGilveray IJ, McKay G, Miller KJ, Patnaik RN, Powell ML, Tonelli A, Viswanathan CT, Yacobi A (2000) Pharm Res 17:1551–1557

    Article  CAS  Google Scholar 

  22. Peters FT, Drummer OH, Musshoff F (2007) Forensic Sci Int 165:216–224

    Article  CAS  Google Scholar 

  23. Peters FT (2006) Method validation using LC-MS. In: Applications of liquid chromatography-mass spectrometry in toxicology. Pharmaceutical Press, London

  24. Schulz M, Iwersen-Bergmann S, Andresen H, and Schmoldt A (2012) Crit Care 16:R136, http://ccforum.com/content/16/4/R136

  25. TIAFT blood level list (2013) http://www.gtfch.org/cms/images/stories/Updated_TIAFT_list_202005.pdf

Download references

Acknowledgments

The authors would like to thank Dr. Andrea E. Steuer for the helpful discussion.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andreas H. Ewald.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Montenarh, D., Hopf, M., Maurer, H.H. et al. Detection and quantification of benzodiazepines and Z-drugs in human whole blood, plasma, and serum samples as part of a comprehensive multi-analyte LC-MS/MS approach. Anal Bioanal Chem 406, 803–818 (2014). https://doi.org/10.1007/s00216-013-7513-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00216-013-7513-x

Keywords

Navigation